APM
IMUX icon

Avidity Partners Management’s Immunic IMUX Stock Holding History

Avidity Partners Management’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.9M Buy
736,935
+266,994
+57% +$2.39M 1.48% 14
2025
Q4 		$2.51M Hold
469,941
– – 0.72% 30
2025
Q3 		$4.14M Sell
469,941
-91,640
-16% -$808K 0.94% 27
2025
Q2 		$3.92M Buy
561,581
+116,140
+26% +$1.07M 0.79% 36
2025
Q1 		$4.86M Sell
445,441
-351,199
-44% -$3.79M 1% 40
2024
Q4 		$7.97M Sell
796,640
-29,960
-4% -$377K 0.79% 46
2024
Q3 		$13.6M Sell
826,600
-63,697
-7% -$907K 0.7% 54
2024
Q2 		$9.88M Hold
890,297
– – 0.42% 62
2024
Q1 		$11.8M Buy
+890,297
New +$11.6M 0.42% 66

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
LCM
Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return